Die vorliegende Arbeit untersuchte die Entwicklung nieder-und hochfrequenter rhythmischer kardiorespiratorischer gesunder Säuglinge. An 15 Probanden erfolgten im Schlaf im ersten Lebenshalbjahr jeweils 13 Messungen mit EKG-Ableitung und induktionsplethysmographischer Registrierung der thorakalen Atemexkursion. Schlafstadienbezogen erfolgten: · die Messung der Amplitude der respiratorischen Sinusarrhythmie (RSA), · die Bestimmung der größten negativen Korrelation zwischen Atemsignal und Herzperiodendauer-Zeitreihe (Kreuzkorrelationskoeffizient, KKK) mit der dazugehörigen Phasenverschiebung mittels Berechnung der Kreuzkorrelationsfunktion und · die Auswertung der Kohärenzspektren von Atmung und Herzaktion. RSA und KKK im ruhigen Schlaf nehmen im Verlauf des ersten Lebenshalbjahres zu. Der Verlauf ist nicht geradlinig, sondern weist signifikante Minima in den ersten Lebenstagen und am Ende der dritten Lebenswoche auf. Die Phasenverschiebung zwischen Atmung und RSA zeigt im ruhigen Schlaf Maxima am 7. und 21. Lebenstag ohne deutlichen Trend innerhalb des Beobachtungszeitraumes. RSA und KKK sind vom ersten Lebenstag an mit Atemfrequenz und Herzfrequenz negativ korreliert. RSA und KKK sind schlafstadienabhängig. Im Gegensatz zum ruhigen Schlaf konnte im aktiven Schlaf weder eine meßbare RSA, noch ein signifikanter KKK gefunden werden. Im Kohärenzspektrum waren jedoch ab dem 150. Lebenstag auch im aktiven Schlaf signifikante gemeinsame Rhythmen im Atemfrequenzbereich nachweisbar. Mit Hilfe der Kohärenzspektren konnten gemeinsame niederfrequente Rhythmen in Atmung und Herzaktion nur in 5.1 % aller Messungen im ruhigen Schlaf und nur in 3.1 % im aktiven Schlaf nachgewiesen werden. Die untersuchten Parameter der Interaktion von Atmung und Herzfrequenz Neugeborener unterscheiden sich von denen Erwachsener in den Absolutwerten. Für RSA und Phasenverschiebung konnte zeigte sich jedoch, daß sich die Werte Erwachsener und Neugeborener nur an verschiedenen Punkten einer gemeinsamen "Arbeitskurve" befinden. Die Ergebnisse lassen auf eine schon zum Zeitpunkt der Geburt vorhandene Reife der kardiorespiratorischen Interaktion schließen. / In the present paper the development of rhythmic cardiorespiratory interactions in low and high frequency ranges were investigated in healthy infants. Data come from a longitudinal study of 14 infants, who were examined for 13 times during sleep during the first 6 months of live. The electrocardiogram and the thoracic respiratory effort were recorded. For quiet and active sleep the following parameters of cardiorespiratory interaction were analysed: · the amplitude of respiratory sinus arrhythmia (RSA), · the highest negative correlation (KKK) and the corresponding phase delay between respiratory signal and time series of heart period duration by means of calculating the cross correlation function and · the coherence in the low and high frequency range. RSA and KKK increase in the first 6 months of live. The course is not linear and has maxima in the first days and at the end of third week. The phase delay shows maxima at 7 th and 21 st day. RSA and KKK are negatively correlated with the respiratory rate and the heart rate from the first day of life up to the 6 th month of life. RSA and KKK depend on sleep state. In opposition to quiet sleep in active sleep neither a measurable RSA nor a significant KKK were found. Contrary, the coherence spectra showed common rhythms in the frequency range of the respiratory rate in the 5 th and 6 th month during active sleep. In the low frequency range common rhythms were observed only seldom, i.e. in 5.1 % of all measurements during quiet sleep and in 3.1 % during active sleep. The analysed parameters of cardiorespiratory interaction of newborns are different from that of adults regarding the absolute values. However the data suggest that the values of newborns and adults represent only different adjustments of a comparable control system. The results indicate a mature cardiorespiratory interaction in healthy newborns.

Being the major energy consumer of electricity and natural gas, buildings consume more than 70% of electricity and 30% of natural gas. On the way to green buildings and zero energy buildings, investigation and improvement of energy efficiency of the buildings will result in significant reductions in energy demands and CO2 emissions / make cost savings and improve thermal comfort as well. Key steps of a successful green, energy efficient building can be summarized as whole building design, site design, building envelope design, lighting and day lighting design and HVAC system design. Energy Plus&reg / software is mainly developed to simulate the performance of the buildings in the view of the above listed points. The design of a building or the analysis of an existing building with the software will show how efficient the building is or will be, and also helps finding the best efficient choice of the whole building system. Thesis focuses on the effect of changes in building envelope properties. In Turkey, topic of green buildings has recently started to be studied. Therefore, this thesis aims to present efficient technologies providing energy savings in buildings, to present green building concept and alternative energy simulation software. In the context of this study, design, methods and material guidelines are introduced to reduce energy needs of buildings and to bring in the green building design concept. Building and system parameters to enhance building energy efficiency and energy savings together with green building principles are summarized. Moreover, whole building energy analysis methods and simulation steps are explained / year-round simulation is performed for a sample building / as a result, energy savings about 36% is achieved.

Aims: To provide 12-month prevalence and disability burden estimates of a broad range of mental and neurological disorders in the European Union (EU) and to compare these findings to previous estimates. Referring to our previous 2005 review, improved up-to-date data for the enlarged EU on a broader range of disorders than previously covered are needed for basic, clinical and public health research and policy decisions and to inform about the estimated number of persons affected in the EU. Method: Stepwise multi-method approach, consisting of systematic literature reviews, reanalyses of existing data sets, national surveys and expert consultations. Studies and data from all member states of the European Union (EU-27) plus Switzerland, Iceland and Norway were included. Supplementary information about neurological disorders is provided, although methodological constraints prohibited the derivation of overall prevalence estimates for mental and neurological disorders. Disease burden was measured by disability adjusted life years (DALY). Results: Prevalence: It is estimated that each year 38.2% of the EU population suffers from a mental disorder. Adjusted for age and comorbidity, this corresponds to 164.8 million persons affected. Compared to 2005 (27.4%) this higher estimate is entirely due to the inclusion of 14 new disorders also covering childhood/adolescence as well as the elderly. The estimated higher number of persons affected (2011: 165 m vs. 2005: 82 m) is due to coverage of childhood and old age populations, new disorders and of new EU membership states. The most frequent disorders are anxiety disorders (14.0%), insomnia (7.0%), major depression (6.9%), somatoform (6.3%), alcohol and drug dependence (> 4%), ADHD (5%) in the young, and dementia (1–30%, depending on age). Except for substance use disorders and mental retardation, there were no substantial cultural or country variations. Although many sources, including national health insurance programs, reveal increases in sick leave, early retirement and treatment rates due to mental disorders, rates in the community have not increased with a few exceptions (i.e. dementia). There were also no consistent indications of improvements with regard to low treatment rates, delayed treatment provision and grossly inadequate treatment. Disability: Disorders of the brain and mental disorders in particular, contribute 26.6% of the total all cause burden, thus a greater proportion as compared to other regions of the world. The rank order of the most disabling diseases differs markedly by gender and age group; overall, the four most disabling single conditions were: depression, dementias, alcohol use disorders and stroke. Conclusion: In every year over a third of the total EU population suffers from mental disorders. The true size of “disorders of the brain” including neurological disorders is even considerably larger. Disorders of the brain are the largest contributor to the all cause morbidity burden as measured by DALY in the EU. No indications for increasing overall rates of mental disorders were found nor of improved care and treatment since 2005; less than one third of all cases receive any treatment, suggesting a considerable level of unmet needs. We conclude that the true size and burden of disorders of the brain in the EU was significantly underestimated in the past. Concerted priority action is needed at all levels, including substantially increased funding for basic, clinical and public health research in order to identify better strategies for improved prevention and treatment for disorders of the brain as the core health challenge of the 21st century.

Background: The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people. Aims: To estimate the number of persons with defined disorders of the brain in Europe in 2010, the total cost per person related to each disease in terms of direct and indirect costs, and an estimate of the total cost per disorder and country. Methods: The best available estimates of the prevalence and cost per person for 19 groups of disorders of the brain (covering well over 100 specific disorders) were identified via a systematic review of the published literature. Together with the twelve disorders included in 2004, the following range of mental and neurologic groups of disorders is covered: addictive disorders, affective disorders, anxiety disorders, brain tumor, childhood and adolescent disorders (developmental disorders), dementia, eating disorders, epilepsy, mental retardation, migraine, multiple sclerosis, neuromuscular disorders, Parkinson's disease, personality disorders, psychotic disorders, sleep disorders, somatoform disorders, stroke, and traumatic brain injury. Epidemiologic panels were charged to complete the literature review for each disorder in order to estimate the 12-month prevalence, and health economic panels were charged to estimate best cost-estimates. A cost model was developed to combine the epidemiologic and economic data and estimate the total cost of each disorder in each of 30 European countries (EU27 + Iceland, Norway and Switzerland). The cost model was populated with national statistics from Eurostat to adjust all costs to 2010 values, converting all local currencies to Euro, imputing costs for countries where no data were available, and aggregating country estimates to purchasing power parity adjusted estimates for the total cost of disorders of the brain in Europe 2010. Results: The total cost of disorders of the brain was estimated at €798 billion in 2010. Direct costs constitute the majority of costs (37% direct healthcare costs and 23% direct non-medical costs) whereas the remaining 40% were indirect costs associated with patients' production losses. On average, the estimated cost per person with a disorder of the brain in Europe ranged between €285 for headache and €30,000 for neuromuscular disorders. The European per capita cost of disorders of the brain was €1550 on average but varied by country. The cost (in billion €PPP 2010) of the disorders of the brain included in this study was as follows: addiction: €65.7; anxiety disorders: €74.4; brain tumor: €5.2; child/adolescent disorders: €21.3; dementia: €105.2; eating disorders: €0.8; epilepsy: €13.8; headache: €43.5; mental retardation: €43.3; mood disorders: €113.4; multiple sclerosis: €14.6; neuromuscular disorders: €7.7; Parkinson's disease: €13.9; personality disorders: €27.3; psychotic disorders: €93.9; sleep disorders: €35.4; somatoform disorder: €21.2; stroke: €64.1; traumatic brain injury: €33.0. It should be noted that the revised estimate of those disorders included in the previous 2004 report constituted €477 billion, by and large confirming our previous study results after considering the inflation and population increase since 2004. Further, our results were consistent with administrative data on the health care expenditure in Europe, and comparable to previous studies on the cost of specific disorders in Europe. Our estimates were lower than comparable estimates from the US. Discussion: This study was based on the best currently available data in Europe and our model enabled extrapolation to countries where no data could be found. Still, the scarcity of data is an important source of uncertainty in our estimates and may imply over- or underestimations in some disorders and countries. Even though this review included many disorders, diagnoses, age groups and cost items that were omitted in 2004, there are still remaining disorders that could not be included due to limitations in the available data. We therefore consider our estimate of the total cost of the disorders of the brain in Europe to be conservative. In terms of the health economic burden outlined in this report, disorders of the brain likely constitute the number one economic challenge for European health care, now and in the future. Data presented in this report should be considered by all stakeholder groups, including policy makers, industry and patient advocacy groups, to reconsider the current science, research and public health agenda and define a coordinated plan of action of various levels to address the associated challenges. Recommendations: Political action is required in light of the present high cost of disorders of the brain. Funding of brain research must be increased; care for patients with brain disorders as well as teaching at medical schools and other health related educations must be quantitatively and qualitatively improved, including psychological treatments. The current move of the pharmaceutical industry away from brain related indications must be halted and reversed. Continued research into the cost of the many disorders not included in the present study is warranted. It is essential that not only the EU but also the national governments forcefully support these initiatives.

Background: Whereas the role of externalizing disorders is relatively well established in predicting the onset of cannabis use (CU) or cannabis use disorder (CUD), the status of anxiety and mood disorders in predicting CU and CUD remains controversial. Objective: (1) To examine cross-sectional and prospective associations of CU and CUD with a range of mental disorders and whether anxiety and mood disorders are associated with CU/CUD after adjusting for externalizing disorders. Methods: N = 1395 community subjects aged 14–17 at baseline were followed-up at three waves prospectively over 10 years. Substance use, substance disorders and mental disorders were assessed using the DSM-IV/M-CIDI. Results: (1) The baseline prevalence rates where 19.3% at t0 for CU and 2.6% for CUD. Cumulative incidence rates at t3 were 54.3% for CU and 13.7% for CUD. (2) In cross-sectional and prospective analyses other substance use disorders, mood and anxiety disorders were associated with CU and CUD. (3) Associations of panic-anxiety with CU and of depressive and bipolar disorders with CU and CUD were significant after controlling for externalizing disorders. Conclusion: A range of psychopathological conditions, including depressive, bipolar and less consistently anxiety disorders as well as the degree of their comorbidity are significantly associated with incident CU and progression to CUD, even when controlling for externalising disorders. A better understanding of this complex interplay may result in better aetiological models and intervention strategies.

Shear-wall dominant multi-story reinforced concrete structures, constructed by using a special tunnel form technique are commonly built in countries facing a substantial seismic risk, such as Chile, Japan, Italy and Turkey. In 1999, two severe urban earthquakes struck Kocaeli and D&uuml / zce provinces in Turkey with magnitudes (Mw) 7.4 and 7.1, respectively. These catastrophes caused substantial structural damage, casualties and loss of lives. In the aftermath of these destructive earthquakes, neither demolished nor damaged shear-wall dominant buildings constructed by tunnel form techniques were reported. In spite of their high resistance to earthquake excitations, current seismic code provisions including the Uniform Building Code and the Turkish Seismic Code present limited information for their design criteria. This study presents experimental investigation of the panel unit having H-geometry. To investigate the seismic behavior of panel buildings, two prototype test specimens which have H wall design were tested at the Structural Mechanics Laboratory at METU. The experimental work involves the testing of two four-story, 1/5-scale reinforced concrete panel form building test specimens under lateral reversed loading, simulating the seismic forces and free vibration tests. Free vibration tests before and after cracking were done to assess the differences between the dynamic properties of uncracked and cracked test specimens. A moment-curvature program named Waller2002 for shear walls is developed to include the effects of steel strain hardening, confinement of concrete and tension strength of concrete. The moment-curvature relationships of panel form test specimens showed that walls with very low longitudinal steel ratios exhibit a brittle flexural failure with very little energy absorption. Shear walls of panel form test specimens have a reinforcement ratio of 0.0015 in the longitudinal and vertical directions. Under gradually increasing reversed lateral loading, the test specimens reached ultimate strength, as soon as the concrete cracked, followed by yielding and then rupturing of the longitudinal steel. The displacement ductility of the panel form test specimens was found to be very low. Thus, the occurrence of rupture of the longitudinal steel, as also observed in analytical studies, has been experimentally verified. Strength, stiffness, energy dissipation and story drifts of the test specimens were examined by evaluating the test results.

Extruded aluminium has become the material of choice for building envelope owing to its lightness, wide range of possibilities for profile design, durability and the eco-friendly attitude. In the light of recent technological developments in metal and glass industries, there has been various new approaches towards aluminum curtain wall systems which are mostly preferred by architects in high-rise buildings. Herein, the panel curtain wall system is determined as innovative and the modern aluminium curtain wall system. Furthermore, in the recent prestigious high-rise buildings, the demand of the architects and the contractors begins to replace the conventional curtain wall system which is constructed via stick construction technique, with panel curtain wall system which is applied to the building in a modular form . The main aim of this study is to investigate why the panel curtain wall system comes to the forefront especially for high-rise buildings. Accordingly, the basic architectural, structural and constructional design principles of unitized aluminium curtain wall systems are defined, analyzed and then the advantages and disadvantages of this system are pointed out from an architectural point of view. In order to evaluate the performance of panel curtain wall system against environmental factors, the facade tests, which are new and still-developing methods in Turkey, are used. The extensive facade tests have been conducted on full-scale specimen under field conditions reproduced in an equipped test chamber by authorized facade testing company and the assessment of this curtain wall performance was provided accordance with related standards. The two story full-size specimen, was 3000 mm to 7600 mm, belongs to one of the prestigious office towers constructed in Istanbul. The facade tests conducted to the specimen include watertightness, air permeability, wind resistance and building movement tests. In this study, the performance criteria of panel curtain wall system were investigated not only against environmental factors but also against human sourced factors. It is expected that this study will provide a guideline for system designers on the future research and development phase and for architects on the selection of curtain wall systems for their buildings due to the conducted test results and other advantages taken throughout this study.

Nach Befunden des Bundes-Gesundheitssurveys 1998/99 (Zusatzsurvey „Psychische Störungen“) litten im Jahr der Erhebung 32% (=15,6 Millionen) der erwachsenen deutschen Bevölkerung im Alter von 18–65 unter einer oder mehreren psychischen Störungen. Jeder dritte Betroffene (36%) steht oder stand im Jahr vor der Erhebung wegen der psychischen Störung in Kontakt mit ambulanten oder stationären psychiatrisch/psychotherapeutischen Diensten oder seinem Hausarzt. Der Anteil von Betroffenen, die eine im weitesten Sinne adäquate Therapie nach modernen wissenschaftlichen Kriterien erhalten, kann konservativ auf ca.10% geschätzt werden. Die niedrige Versorgungsquote betrifft dabei nicht alle spezifischen Störungsgruppen in gleichem Ausmaß; niedrige Versorgungsraten ergaben sich insbesondere für somatoforme und Suchterkrankungen. Ferner ergaben sich zum Teil markante regionale Unterschiede (z.B. besonders schlechte Versorgungslage in Regionen, die weder über eine nahe Universität noch über psychotherapeutische Weiterbildungsinstitutionen verfügen).Ungeachtet unterschiedlich weiter oder enger Definitionen des Begriffs Behandlungsbedarf, zeigt sich eine gravierende Unterversorgung von Personen mit psychischen Erkrankungen. Quantitativ bedeutsame Hinweise auf eine Fehl- oder Überversorgung von Betroffenen lassen sich nicht aufzeigen. / Data from the German Health Interview and Examination Survey, Mental Health Supplement (N=4181) reveal that 32% (15,6 million people) of the adult population between 18 and 65 years of age suffer from one or more mental disorders. Among those only 36% receive treatment which also varies in type, duration, and adequacy. The proportion of cases receiving “adequate evidence- based treatments” was estimated to be about 10%.Lowest treatment rates were found for somatoform disorders and substance abuses, highest for psychotic disorders, panic disorder, generalised anxiety disorder, and dysthymia. The data reveal substantial regional differences with regard to treatment rates (e.g. lower rates in regions without universities or institutions offering postgraduate mental health education).The paper concludes that, depending on the diagnosis, a considerable degree of unmet medical needs exist for the majority of people affected by mental disorders. No evidence was found for an excessive supply of health care for the patients suffering from mental disorders or for treatments without an existing clinical need.

Background: Over the past decades the public health relevance of mental health conditions in children and adolescents has been of growing concern. However, so far no detailed epidemiological data has been available for a representative national sample in Germany. Objectives: The present paper reports prevalence rates of general and specific mental health problems among children and adolescents in Germany and describes the link between symptoms and impairment as well as the treatment situation. Methods: The mental health module (BELLA study) examines mental health problems in a representative sub-sample of 2,863 families with children aged 7–17 from the National Health Interview and Examination Survey among Children and Adolescents (KiGGS). Mental health problems were determined using the extended version of the strengths and difficulties questionnaire (SDQ). Further standardised screening measures were employed to screen for anxiety disorders (SCARED), conduct disorder (CBCL), attention deficit-/ hyperactivity disorder (FBBHKS, Conners’ Scale) and depressive disorders (CES-DC). Furthermore, substance abuse and suicidal tendencies were assessed. Health-related quality of life (HRQoL) and health care use were determined. Results Overall, 14.5% of the children and adolescents aged 7–17 fulfilled the criteria for at least one specific mental health problem associated with impairment, or had an overall mental health problem indicated by an abnormal SDQ score and present impairment. However, high comorbidity was found in the children concerned. Symptoms of overall mental health problems were present in 8.6% of the children and 6.6% of the adolescents. This number was reduced to prevalence rates of 6.3 and 4.9% when additional impairment was taken as a criterion. Irrespective of the type of disorder, fewer than half of the children affected were reported as receiving treatment. However, for those suffering from mental health problems, large impairments in HRQoL were observed. Conclusions: The observed prevalence of mental health problems as well as their large impact on well-being and functioning calls for early prevention. This is especially important with regard to the large decrease in HRQoL in the children and adolescents affected.

Im Rahmen einer Reanalyse von vier Erhebungen an jugendlichen und erwachsenen Probanden in den neuen und alten Bundesländern in den Jahren 1990 bis 1991/92 wurden Angaben zu Indikatoren für Depressivität, Angst/psychosomatische Beschwerden und Substanzgebrauch in Ost- und Westdeutschland verglichen. Zum Zeitpunkt der Untersuchungen gab es im Gegensatz zu der von einzelnen Autoren angeführten Erwartung keine eindeutigen Hinweise auf eine insgesamt erhöhte psychiatrische Morbidität in den neuen Bundesländern. Depressive Symptome und der Gebrauch von illegalen Drogen und Medikamenten sind durchgängig in den alten Bundesländern häufíger nachzuweisen als in den neuen Bundesländern. Allenfalls ergaben sich für die Stichproben Ost für einzelne depressionstypische sowie einzelne psychovegetative Symptome und für Alkoholgebrauch statistisch signifikant erhöhte Werte. Da keine Diagnosekriterien erhoben wurden, muβ die Aussagekraft der Daten dahingehend eingeschränkt werden, daβ lediglich Indikatoren für psychische Auffälligkeiten erhoben wurden.